Gencell Ltd carries a market capitalization of 2.73M, placing it among publicly traded companies globally. Its enterprise value stands at -4.59M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.73M |
| Enterprise Value | -4.59M |
Gencell Ltd currently has 22.31M shares outstanding.
| Shares Outstanding | 22.31M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | 0.32 |
| P/TBV Ratio | 0.32 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Gencell Ltd maintains a current ratio of 2.24, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.24 |
| Quick Ratio | 1.00 |
| Debt / Equity | 1.68 |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Gencell Ltd's stock has declined approximately -60% over the past 52 weeks. The 50-day moving average sits at 0.20, while the 200-day moving average is 0.31.
| Beta (5Y) | N/A |
| 52-Week Price Change | -60% |
| 50-Day Moving Average | 0.20 |
| 200-Day Moving Average | 0.31 |
| Average Volume (20 Days) | N/A |
Gencell Ltd holds 9.12M in cash and equivalents against 222,456.50 in total debt, resulting in a net debt position of -9.12M. Total book value stands at 13.26M, with working capital of 11.33M providing operational flexibility.
| Cash & Cash Equivalents | 9.12M |
| Total Debt | 222,456.50 |
| Net Debt | -9.12M |
| Equity (Book Value) | 13.26M |
| Book Value Per Share | 0.59 |
| Working Capital | 11.33M |
Gencell Ltd posts an Altman Z-Score of -67.88, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -67.88 |